Cellexus Biosystems of Cambridgeshire, UK, has announced the appointment of JM Finn and Co of London, UK, as the company's new corporate advisor, effective immediately
Kevin Auton, CEO of Cellexus Biosystems stated "We are delighted to be working with the team at JM Finn and are looking forward to an exciting 24 months ahead.
"Having only just listed on Ofex, we continue to implement our operational plan, which is on track and to budget.
"As we looked to the future, we saw that JM Finn would bring an added dimension to the company as we prepare for a listing on London's Alternative Investment Market (AiM) in 2007, when the timing is right for us.
"With JM Finn's recently achieved status as an AiM nominated advisor, combined with their acknowledged expertise in corporate finance, we believe this appointment to be a fundamental step forward in achieving our long-term goals."
